Dusigitumab
Istiratumab
Lonigutamab
Xentuzumab
Dalotuzumab
Ganitumab
Figitumumab
Robatumumab
Teprotumumab
Cixutumumab
Veligrotug
IGF-I (30-41) (TFA)
IGF-I (24-41)
IGF-I (24-41) (TFA)
Chimaphilin
AZ7550
AZ7550 hydrochloride
AZ7550-d 5
IndirubinDerivativeE804
IGF-1R inhibitor-3